Aquatic Capital Management’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $417K | Sell |
2,417
-28,093
| -92% | -$4.85M | 0.01% | 871 |
|
|
2025
Q1 | $4.76M | Buy |
30,510
+28,836
| +1,723% | +$4.49M | 0.12% | 222 |
|
|
2024
Q4 | $230K | Buy |
+1,674
| New | +$230K | 0.01% | 898 |
|
|
2024
Q2 | – | Sell |
-4,300
| Closed | -$650K | – | 1215 |
|
|
2024
Q1 | $650K | Buy |
+4,300
| New | +$650K | 0.02% | 490 |
|
|
2023
Q4 | – | Sell |
-2,800
| Closed | -$262K | – | 1315 |
|
|
2023
Q3 | $262K | Sell |
2,800
-100
| -3% | -$9.36K | 0.01% | 622 |
|
|
2023
Q2 | $259K | Buy |
2,900
+400
| +16% | +$35.7K | 0.01% | 601 |
|
|
2023
Q1 | $268K | Buy |
+2,500
| New | +$268K | 0.02% | 529 |
|